Skip to content

Gross margin at other companies

AdaptHealth logo
AdaptHealthAHCO
18.3%-1.6pp
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
20.2%+4.9pp
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
18.6%-1.0pp
ResMed logo
ResMedRMD
61.6%+2.8pp
UFP Technologies logo
UFP TechnologiesUFPT
28.4%-0.6pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Calculated from Viemed Healthcare, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s gross margin?
Viemed Healthcare, Inc. (VMD) reported gross margin of 57.6% in Q1 2026.
How has Viemed Healthcare, Inc.'s gross margin changed year-over-year?
Viemed Healthcare, Inc.'s gross margin decreased by 1.9% year-over-year, from 58.7% to 57.6%.
What is the long-term trend for Viemed Healthcare, Inc.'s gross margin?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s gross margin has grown at a -1.2% compound annual growth rate (CAGR), from 61% to 57.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.